Oct 22 (Reuters) - BIONTECH SE:

* BIONTECH COMMENCES PUBLIC EXCHANGE OFFER FOR ALL

OUTSTANDING

SHARES OF CUREVAC N.V.

* UNDER TERMS OF PURCHASE AGREEMENT, EACH CUREVAC SHARE WILL

BE

EXCHANGED FOR APPROXIMATELY $5.46 IN BIONTECH AMERICAN

DEPOSITARY

* CUREVAC SHAREHOLDERS RECEIVE APPROXIMATELY $5.46 IN

BIONTECH

AMERICAN DEPOSITARY SHARES FOR EACH CUREVAC SHARE

* OFFER WILL EXPIRE AT 9:00 A.M. (NEW YORK CITY TIME) ON

DECEMBER

3, 2025

* OFFER IS SUBJECT TO VARIOUS CONDITIONS, INCLUDING AT LEAST

80%

OF CUREVAC'S SHARES BEING TENDERED

* AND CUREVAC WILL EFFECTUATE A CORPORATE REORGANIZATION OF

CUREVAC AND ITS SUBSIDIARIES, RESULTING IN BIONTECH OWNING 100%

OF CUREVAC'S BUSINESS

* SUBJECT TO A COLLAR MECHANISM, SUCH THAT IF 10-DAY VOLUME

WEIGHTED AVERAGE PRICE OF A BIONTECH ADS ENDING ON, AND

INCLUDING, FIFTH BUSINESS DAY PRIOR TO CLOSING OF OFFER ("VWAP")

IS GREATER THAN OR EQUAL TO $126.55, EACH CUREVAC SHARE WILL BE

EXCHANGED ( "EXCHANGE RATIO") FOR 0.04318 OF A BIONTECH ADS

* AND IF VWAP IS LESS THAN OR EQUAL TO $84.37, EXCHANGE

RATIO WILL

BE 0.06476 OF A BIONTECH ADS

Source text:

Further company coverage:

(Gdansk Newsroom)

;))